Immunology and Microbiology
Human Immunodeficiency Virus
100%
Simian Immunodeficiency Virus
59%
Human Immunodeficiency Virus 1
53%
Macrophage
48%
Macaca
33%
Monocyte
26%
Myeloid
24%
Viral Load
23%
Drug Resistance
22%
Reverse Transcriptase
20%
T-Helper Cell
16%
Human T-Lymphotropic Virus 1
15%
Rebound
13%
Prevalence
12%
Human Immunodeficiency Virus Type 1 Subtype C
11%
Central Nervous System
11%
Viral Disease
11%
Human Immunodeficiency Virus Type 1 Subtype B
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Integrase
10%
Blood Plasma
9%
Virus Infectivity
9%
CD4
8%
Cell Surface
8%
Lymphocyte
7%
Molecular Weight
7%
Microglia
7%
Cerebrospinal Fluid
6%
Coinfection
6%
Candida Albicans
6%
Encephalitis
6%
Candida
6%
Protein Degradation
6%
Brain Tissue
6%
Gp41
5%
Lineages
5%
Genetic Variability
5%
Human T-Lymphotropic Virus
5%
in Vitro Selection
5%
Trypanosomatid
5%
Induced Pluripotent Stem Cell
5%
Protein Content
5%
Protein Expression
5%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Defective Interfering Particle
5%
COVID-19
5%
Cognition
5%
Inflammation Response
5%
Wild Type
5%
Human Immunodeficiency Virus 2
5%
Keyphrases
Simian Immunodeficiency Virus
40%
Antiretroviral Therapy
38%
Human Immunodeficiency Virus Type 1 (HIV-1)
34%
Macaque
26%
Macrophages
25%
Mozambique
24%
AIDS/HIV
22%
Viral Load
20%
Resistance mutations
18%
Polymorphism
16%
Latent Reservoir
15%
Brain Macrophages
15%
Myeloid Cells
13%
Monocytes
13%
Virus
12%
Reverse Transcriptase
12%
Virus Reservoir
11%
Latency
11%
Virus Infection
10%
Maputo-Mozambique
10%
Herpetomonas Samuelpessoai
10%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
10%
Protease
10%
Extracellular Vesicles
10%
Drug Resistance mutations
10%
Gp41
10%
HIV Drug Resistance
10%
Brazil
10%
Enfuvirtide
10%
Ingenol
10%
Maputo City
10%
Highly Active Antiretroviral Therapy (HAART)
9%
Antiretroviral
9%
CD4+ T Cells
9%
Integrase
8%
HIV Latency
8%
Cerebrospinal Fluid
8%
CD4+ Lymphocytes
8%
Infectious Virus
8%
Latently Infected
7%
Viral Outgrowth Assay
7%
Quantitative PCR
7%
COVID-19
7%
Central Nervous System
6%
Natural Polymorphism
6%
Virological Failure
6%
People Living with HIV (PLHIV)
6%
Brain Tissue
6%
Small Interfering RNA (siRNA)
6%
Primary HIV Infection
6%
